Vaqta® Pediatric Hepatitis A Vaccine Indicated for People 12 Months Through 18 Years of Age 25 Unit / 0.5 mL Injection Prefilled Syringe 0.5 mL

Features

• VAQTA® [Hepatitis A Vaccine
• Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older VAQTA is a sterile suspension for intramuscular injection One milliliter of the vaccine contains approximately 50U of hepatitis A virus antigen
• which is purified and formulated without a preservative Each 0.5-mL pediatric dose contains 25U of hepatitis A virus antigen and adsorbed onto approximately 0.225 mg of aluminum provided as amorphous aluminum hydroxy phosphate sulfate
• and 35 mcg of sodium borate as a pH stabilizer
• in 0.9% sodium chloride